Menopause-Associated Lipid Metabolic Disorders and Foods Beneficial for Postmenopausal Women

Abstract

Menopause is clinically diagnosed as a condition when a woman has not menstruated for one year. During the menopausal transition period, there is an emergence of various lipid metabolic disorders due to hormonal changes, such as decreased levels of estrogens and increased levels of circulating androgens; these may lead to the development of metabolic syndromes including cardiovascular diseases and type 2 diabetes. Dysregulation of lipid metabolism affects the body fat mass, fat-free mass, fatty acid metabolism, and various aspects of energy metabolism, such as basal metabolic ratio, adiposity, and obesity. Moreover, menopause is also associated with alterations in the levels of various lipids circulating in the blood, such as lipoproteins, apolipoproteins, low-density lipoproteins (LDLs), high-density lipoproteins (HDL) and triacylglycerol (TG). Alterations in lipid metabolism and excessive adipose tissue play a key role in the synthesis of excess fatty acids, adipocytokines, proinflammatory cytokines, and reactive oxygen species, which cause lipid peroxidation and result in the development of insulin resistance, abdominal adiposity, and dyslipidemia. This review discusses dietary recommendations and beneficial compounds, such as vitamin D, omega-3 fatty acids, antioxidants, phytochemicals—and their food sources—to aid the management of abnormal lipid metabolism in postmenopausal women.

Gender Differences in the Association between Sleep Duration and Cardiometabolic Risk: A Cross-sectional Study

“…This could be related to the abnormal lipid metabolism that begins to be seen from around 50 years of age in women. Estrogen de ciency due to menopause has been reported to have a signi cant impact on lipid metabolism in females [36,37]. In the present study, as shown in Figure 4, serum LDL-C and non-HDL-C levels and triglyceride increased rapidly and serum HDL-C levels tended to decrease, though gradually, from around 50 years of age in females.…”

Prevalence and epidemiological determinants of metabolically obese but normal-weight in Chinese population

“…We also found that menopause increased MONW risk (having adjusted for the confounding effect by age). Therefore, combining these results, it appears that estrogen may be a protective factor for maintaining metabolic health in normal-weight females [23,24].…”

Cardiovascular risk markers in women with metabolic syndrome at the menopausal transition using multimodal non-drug therapies

“…Биопотенциал Ессентукских минеральных вод, за счет активации энтероинсулярных гормональных взаимодействий, способствовал нормализации перекисного гомеостаза, снижению инсулинорезистентности и как следствие улучшению углеводного и липидного обмена, предотвращая прогрессирование метаболических нарушений [25]. Необходимость включения в программу витаминов и минералов как мощных антиоксидантов и регуляторов всех видов обмена на фоне возрастающей потребности в микроэлементах у женщин зрелого возраста явилась очевидной для предотвращения глубоких дефектов метаболизма белков, жиров, углеводов, электролитного обмена [26,27]. Терапевтическое воздействие музыки заключалось в коррекции психоэмоционального статуса посредством ритмического раздражения слуховых рецепторов, воздействия на лимбическую систему, активации метаболизма, нормализации функционирование дыхательной и сердечно-сосудистой систем [28].…”